Abdominal wall pain Anterior Cutaneus Nerve Entrapment
Conditions
Interventions
Fase 1, diagnosis: Patients will be randomized into two groups. One group will be infiltrated with 10 cc lidocaine at the triggerpoint, the control group will be infiltrated with 10cc of saline. Evalu
Sponsors
Performer: drs. O.B.A. Boelens
Eligibility
Inclusion criteria
Inclusion criteria: 1. Unilateral abdominal triggerpoint in rectus muscle; 2. More than 1 month continues pain; 3. Complaints worsen on fysiacal activity; 4. Positive Carnett's sign.
Exclusion criteria
Exclusion criteria: 1. Age below 18 years; 2. Recent intra-abdominal pathology; 3. Proven lidocaine allergy; 4. Anticoagulants; 5. Coagulopathy; 6. No follow-up possible: mental retardation, dementia, impaired communicatio due to language.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fase 1: The difference in number of patients with a clinically relevant reduction of pain measured on VAS of at least 50 %, 15 minutes after infiltration of Lidocaine vs Saline. Fase 3: The difference in number of patients with a clinically relevant reduction of pain measured on VAS of at least 50 %, 6 weeks after neurectomy vs sham. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fase 1: Difference in the number of patients with longterm painfree result after diagnostic injection (VAS<10); absolute and relative difference on VAS; Difference on Verbal Rating Scale. Fase 2: the number of patients with a painfree result after infiltration with lidocain and corticosteroids at follow-up of hree months. Fase 3: Longterm evaluation: frequncy of patients developing a recurrent pain at the site of surgery after a painfree period of at least 6 weeks. Difference on Verbal Rating Scale. Improvement on FS-36. | — |
Contacts
Public ContactO.B.A. Boelens
Surgical Department Maxima Medisch Centrum Veldhoven P.O.Box 7777
Outcome results
None listed